Medtech Industry Veteran Hooman C. Hakami New Chairman of PathMaker Neurosystems BOD

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neuromodulation company developing breakthrough non-invasive systems for the treatment of patients with serious neurological disorders such as stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI), has named Hooman C. Hakami as Chairman of the Company’s Board of Directors.  Mr. Hakami is currently the Managing Director of Hakami Healthcare Advisors, LLC where he provides advisory services to Boards and CEOs in the healthcare space.  Previously, he was with Medtronic, where he served as Executive Vice President and President of the Diabetes Group.

“I am delighted to have Hooman Hakami joining PathMaker as Chairman of the Board of Directors,” said Nader Yaghoubi, M.D., Ph.D., President and Chief Executive Officer of PathMaker. “As we approach commercialization, Hooman’s invaluable experience leading and operating global medtech companies will be an exceptional addition to our Board. I am confident his strategic insights will be instrumental as we take PathMaker to initial  regulatory approval next year on MyoRegulator®, the world’s first non-invasive neuromodulation device for the treatment of muscle spasticity.”

“I am pleased to be joining PathMaker.” Mr. Hakami commented. “The Company has the only non-invasive, multi-site neuromodulation system in the world.  This pioneering approach to treating neurological disease has the potential to bring about a new standard of care – through improved outcomes, lower cost and a better patient experience – for a number of serious conditions in urgent need of innovation, including Spasticity and ALS.  I look forward to helping guide the path of the Company.”

Mr. Hakami has 30 years of leadership experience, having been responsible for running multi-billion dollar businesses and managing thousands of employees on a global scale.  Prior to Medtronic, he spent more than 20 years at General Electric, where he was a Company Officer. There, he served as President and CEO of Detection and Guidance Solutions at GE Healthcare.  Prior to this he served as President and CEO of the Interventional Systems business based in France, and the Global Clinical Systems Services for GE Healthcare.




Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.